Serotonin Made in Breast Cancer Cells, Researchers Show

Nov 24, 2009
Serotonin Made in Breast Cancer Cells, Researchers Show
Nelson Horseman, PhD

(PhysOrg.com) -- Researchers at the University of Cincinnati have documented that the brain hormone serotonin is made in human breast cancer cells and functions abnormally, contributing to malignant growth.

Researchers in the lab of Nelson Horseman, PhD, a professor in the department of molecular and cellular physiology, published their findings this month in Breast Cancer Research, a peer-reviewed online journal. The study represents the first report of direct involvement of in human breast cancer.

Horseman’s team has previously shown that serotonin, a neurotransmitter best known for its involvement in mood regulation, plays a role in mammary gland development. Armed with that knowledge, researchers analyzed human breast tumors from patients and in a laboratory setting to determine if serotonin played a role in breast cancer.

In a normal mammary gland, serotonin acts as a physiological regulator of lactation and involution (shrinkage of the milk-making system when it’s not needed), in part by favoring growth arrest and cell death. Researchers found that the serotonin system was subverted in two important ways in human breast cancers.

“First, the amount of serotonin that the breast synthesize changes abnormally,” Horseman says. “And second, breast cancer cells have receptors for serotonin that are different from normal , so they receive the serotonin signal in a different way—and that contributes to abnormal growth.”

The findings open a possible new avenue for diagnosis and prognosis of human , Horseman says, and could provide valuable new therapeutic targets for managing the disease, the second-leading cause of cancer death (behind only lung cancer) among American women.

Horseman points out that a number of drugs are in use that affect serotonin levels, including (SSRIs) such as the antidepressants Prozac, Zoloft and Paxil. Further study is needed, he says, to explore their potential anti-cancer benefits.

Provided by University of Cincinnati (news : web)

Explore further: PET-CT predicts lymphoma survival better than conventional imaging

add to favorites email to friend print save as pdf

Related Stories

Breast stem cell fate is regulated by 'notch'

Oct 08, 2008

A normal developmental protein that sometimes goes awry has been implicated in breast cancer. This discovery indicates the mechanism by which inappropriate expression of the Notch pathway may contribute to breast cancer.

Sex differences in the brain's serotonin system

Feb 13, 2008

A new thesis from he Swedish medical university Karolinska Institutet shows that the brain’s serotonin system differs between men and women. The scientists who conducted the study think that they have found one of the reasons ...

Recommended for you

Chromosome buffers hold key to better melanoma understanding

11 hours ago

Buffers that guard against damage to the ends of chromosomes could hold the key to a better understanding of malignant melanoma – the deadliest form of skin cancer – according to new research from the University of Leeds.

User comments : 0